A Study of Reolysin For Patients With Advanced/Metastatic Breast Cancer
Status:
Completed
Trial end date:
2018-02-14
Target enrollment:
Participant gender:
Summary
Researchers doing this study want to evaluate the side effects of Reolysin when given
together with paclitaxel. As these drugs have not been given together before, 6-9 patients
will be treated with paclitaxel plus reolysin to ensure that side effects are tolerable.